The Centers for Disease Control and Prevention has updated guidance for critical infrastructure workers’ return to work following exposure to COVID-19. The interim guidance, which applies to personnel in 16 different sectors, permits continued work following potential COVID-19 exposure “provided they remain asymptomatic and additional precautions are implemented to protect them and the community.”

It also details practices workers and employers should follow prior to and during work shifts, including pre-screening, regular monitoring, the use of a face mask for 14 days following last exposure, social distancing, and disinfecting and cleaning work spaces and shared equipment.

CDC also clarified allowances for other swab types using new data and to align with Food and Drug Administration guidance by designating the following as acceptable alternatives to nasopharyngeal swabs:

  • oropharyngeal specimen collected by a health care professional;
  • nasal mid-turbinate swab collected by a health care professional or by onsite self-collection (using a flocked tapered swab); or
  • anterior nares (nasal swab) specimen collected by a health care professional or by onsite self-collection (using a flocked or spun polyester swab).

Related News Articles

Headline
The Food and Drug Administration Nov. 9 cleared for marketing the Flowflex COVID-19 Antigen Home Test, the first COVID-19 antigen test and second COVID-19 at-…
Headline
Fewer than one in four health care professionals working in acute care hospitals and nursing homes were up to date with COVID-19 vaccination during the 2022-23…
Headline
Children under age 12 should receive a 0.25 milliliter dose of the 2023-24 Moderna COVID-19 vaccine, not the full vial for that age group, the Food and Drug…
Headline
The Department of Health and Human Services Oct. 27 urged Merck and Pfizer to work with private insurers to maintain access to their COVID-19 oral antiviral…
News
To enjoy a healthy Thanksgiving with family and friends, get vaccinated against the flu and COVID-19. That’s the message of AHA’s latest United Against the Flu…
Headline
The Food and Drug Administration recently extended to 30 months the shelf life for certain lots of Gohibic (vilobelimab), authorized for emergency…